跳至主要内容
临床试验/NCT03333369
NCT03333369已完成早期 1 期

L-Dopa Modulated Striatal Functional Connectivity in Schizotypal Adults: a Randomized Double-blind Placebo-controlled Study

University of Zurich1 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2014年5月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
65
试验地点
1
主要终点
intrinsic functional connectivity

研究概览

简要总结

The dopamine hypothesis of schizophrenia implies that alterations in the dopamine system cause functional abnormalities in the brain that may converge to aberrant salience attribution and eventually lead to psychosis. Indeed, widespread brain disconnectivity across the psychotic spectrum has been revealed by resting-state functional magnetic resonance imaging (rs-fMRI). However, the dopaminergic involvement in intrinsic functional connectivity (iFC) and its putative relationship to the development of psychotic spectrum disorders remains partly unclear - in particular at the low-end of the psychosis continuum. Therefore, the investigators examined dopamine-induced changes in striatal iFC and their modulation by psychometrically assessed schizotypy. The randomized, double-blind placebo-controlled study design included 54 healthy, right-handed male participants. Each participant was assessed with the Schizotypal Personality Questionnaire (SPQ) and underwent 10 min of rs-fMRI scanning. Participants then received either a placebo or 200 mg of L-DOPA, a dopamine precursor. The investigators analyzed iFC of six striatal seeds that are known to evoke modulation of dopamine-related networks.

The investigators hypothesized that, within the L-DOPA treatment group, the striatal iFC would be disrupted due to increased availability of dopamine. The investigators further hypothesized that individuals with high schizotypal scores would show a disruption of striatal connectivity, as has been reported with schizophrenia. In addition, the investigators hypothesized that the L-DOPA-dependent change in striatal iFC would interact with the severity of positive symptoms, as has been found in previous studies in non-clinical psychosis. The investigators anticipated this symptom-dependent change, especially in the ventral striatal regions, because these are thought to modulate cortico-striatal loops associated with cognition and emotion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

For the randomization of the intervention and placebo the "Research Randomizer" on www.randomizer.org will be used. The randomization will be performed by the Kantonsapotheke in Zurich. The generated list of condition sequences will be stored at there. The list will not be accessible for study members who are associated with the assessment. The Boxes containing the cachets will be labelled with the subject number and A or B for the first or second session, respectively as well as with the ID of the study. The cachets will be prepared and labelled at the Kantonsapotheke in Zurich. DA and placebo will be provided in identical cachets. The blinding will be broken only after a subject has completed both experimental sessions or in case of an acute reaction during the session.

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Between 20 and 40 years of age,
  • With exceptional experiences or skeptics,
  • Caucasian origin,
  • Normal visual and acoustic accuracy.

排除标准

  • Persons with a personal or first-degree family history of neurological and psychiatric disease, including impaired cognitive abilities,
  • Pregnant or breastfeeding women,
  • Chronic or acute pain,
  • Acute or chronic somatic disease,
  • Women (i.e. only men included),
  • Men over 40 years of age or below 20,
  • left- or mixed-handedness,
  • General MRI exclusion criteria,
  • General Dopamine-Challenge exclusion criteria,
  • Hormonal or herbal therapy,

研究组 & 干预措施

Madopar Arm

Active Comparator

A single dose of a cachet filled with 200 mg levodopa/50 mg benserazide

干预措施: 200 mg levodopa/50 mg benserazide (Drug)

Placebo Arm

Placebo Comparator

A single dose of a cachet filled with Dextrose

干预措施: Dextrose (Drug)

结局指标

主要结局

intrinsic functional connectivity

时间窗: 2 hours

Dopamine dependent intrinsic functional connectivity as measured by resting-state functional magnetic resonance imaging

次要结局

  • Schizotypy(15 min)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Exceptional Experiences (EE), Salience &... | 临床试验